Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of an investigational agent for liver disease in Japan
jRCT2080224933Phase 2Terminated
- Start
- Oct 2019
01
Overview
Phase 2 trial in hepatic disease. Started Oct 2019; status: terminated.
02
Conditions
hepatic disease
Beyond the preview
Go deeper on jRCT2080224933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224933.